IRCT20171119037543N2Recruiting未知
Evaluating the Effects of Synbiotic on Preventing Antibiotic Associated Diarrhea in children admitted in Imam Hosein Hospital in Isfahan City
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 months to 14 years (—)
- Sex
- All
Inclusion Criteria
- •Children with 2 months to 14 years age
- •Children who are admitted in Imam Hosein Hospital in Isfahan City
- •Children who are candidate for Antibiotic therapies due to infections for equal and more than 5 days
- •Parent's willingness to participating in this study
Exclusion Criteria
- •Acute or chronic diarrhea before starting Antibiotic
- •Having Antibiotic therapy during last 2 months
- •Having prophylactic Antibiotic treatment
- •Having Clostridium Difficile Associated Diarrhea during last 3 months
- •Having underlying gastrointestinal disease
- •Having central vein catheterization
- •Having history of using probiotics during last 7 days
- •Having immune deficiency
- •Having underlying cardiovascular disease
- •Having sever malnutrition or sever illness
- •Having long term use of medications with gastrointestinal effects
Investigators
Similar Trials
Completed
Not Applicable
Synbiotic for prevention of common cold in asthmatic childreAsthmaAsthma.IRCT201509234976N3vice chancellor for research, Mashhad University of medical sciences.72
Completed
Phase 3
Outcome of synbiotics on necrotizing enterocolitis, sepsisCondition 1: Necrotizing enterocolitis. Condition 2: Sepsis. Condition 3: Hyperbilirubinemia.Necrotizing enterocolitis of fetus and newbornBacterial sepsis of newbornNeonatal jaundice from breast milk inhibitorIRCT2013062710279N3OBEL Pharmacy210
Recruiting
Phase 2
SSG-01 studyColorectal cancerJPRN-jRCTs041210057Ogura Atsushi160
Recruiting
Phase 3
Effect of synbiotics in treatment of diarrheaIRCT20181231042190N1Ahvaz University of Medical Sciences120
Recruiting
Unknown
Preventive symbiotic administration on the incidence of allergic diseases in children aged 0 to 5 yearsIRCT20211211053351N2Mashhad University of Medical Sciences400